SUBSCRIBE
SUBSCRIBE

Europe

Nature V. Nurture: Divorce Could Be Genetic, Lund University Study Reveals
October 6, 2017
 · 
1 min read
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
Deals
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
October 6, 2017
 · 
2 min read
Bayer Halts Phase III Study on New Xarelto Indication
Drug Development
Bayer Halts Phase III Study on New Xarelto Indication
October 6, 2017
 · 
2 min read
Bayer Halts Phase III Study on New Xarelto Indication
Policy
Outrage Leads Senator to Draft Bill in Response to Allergan’s ‘Should-be-Illegal’ Patent Maneuver
October 6, 2017
 · 
2 min read
Different Types Of Meditation Change The Brain In Different Ways, Max Planck Institute Study Reveals
October 5, 2017
 · 
1 min read
Deals
UK Drugmaker Pays Up To $80 Million For Bay Area’s Roxwood Medical
October 5, 2017
 · 
1 min read
Faster, Pricier And Often Worthless: Study Slams Regulators For Wave Of Questionable Cancer Drug OKs
October 5, 2017
 · 
1 min read
Business
AstraZeneca PLC May Move Some Manufacturing, R&D Out Of The UK Due To Brexit
October 4, 2017
 · 
1 min read
Researchers May Have Discovered A Way To Reverse Blindness, University of Oxford Study Reveals
October 4, 2017
 · 
1 min read
Llama-Derived Nanobodies As A New Tool In Solving Crystal Structure, Aarhus University Study
October 3, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June 2026
May 28, 2026
 · 
2 min read
Press Releases
KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema
May 28, 2026
 · 
8 min read
Press Releases
Compass Pathways Elects Kathleen Tregoning to Board of Directors
May 28, 2026
 · 
7 min read
Press Releases
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
May 28, 2026
 · 
2 min read
Press Releases
TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer
May 28, 2026
 · 
3 min read
Press Releases
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
May 28, 2026
 · 
6 min read
Press Releases
Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)
May 28, 2026
 · 
2 min read
Press Releases
Merz Therapeutics Presents New Research at World Parkinson Congress 2026, Revealing the Hidden Burden of “OFF” Episodes in Parkinson’s Disease
May 28, 2026
 · 
4 min read
Press Releases
Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
May 28, 2026
 · 
4 min read
Press Releases
Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation
May 28, 2026
 · 
5 min read
Press Releases
ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics
May 28, 2026
 · 
4 min read
Press Releases
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
May 28, 2026
 · 
11 min read
Press Releases
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
 · 
5 min read
Press Releases
New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer
May 28, 2026
 · 
3 min read
Press Releases
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
May 28, 2026
 · 
7 min read
Press Releases
New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
May 28, 2026
 · 
10 min read
Press Releases
argenx to Host Myositis R&D Webinar on June 23, 2026
May 28, 2026
 · 
1 min read
Press Releases
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
 · 
8 min read
Press Releases
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
May 28, 2026
 · 
20 min read
Press Releases
Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards
May 27, 2026
 · 
6 min read
Load More